Roche expects an increase in Group sales in the mid single digit range. Core earnings per share are targeted to grow in the high single digit range, excluding the impact from the resolution of tax disputes in 2023. Roche expects to further increase its dividend in Swiss francs.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RHHBY:
- [Ad hoc announcement pursuant to Art. 53 LR] Roche sales increase by 5% (CER) in first half of 2024; strong growth in second quarter – full-year earnings outlook raised
- Roche failure removes potential downside for Apellis, says Baird
- Stock Market News Today, 7/19/24 – Indices Fall as Investors Rotate out of Megacaps
- Genentech announces two-year data from Pagoda, Pavilion studies
- New data for Roche’s Susvimo demonstrates sustained efficacy in two serious diabetic eye conditions
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue